Nalaganje...
Effect of once‐weekly dulaglutide versus insulin glargine in people with type 2 diabetes and different baseline glycaemic patterns: A post hoc analysis of the AWARD‐2 clinical trial
The long‐acting glucagon‐like peptide‐1 receptor agonist dulaglutide acts by stimulating insulin secretion and reducing glucagon levels in a glucose‐dependent manner both in the fasting and postprandial states, resulting in reductions of both fasting glucose (FG) and postprandial glucose (PPG). In c...
Shranjeno v:
| izdano v: | Diabetes Obes Metab |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Blackwell Publishing Ltd
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6852007/ https://ncbi.nlm.nih.gov/pubmed/31364266 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13844 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|